Stocks with share prices under $5 (aka " penny stocks ") are typically too risky to consider. The current economic environment, however, has pushed several intriguing, innovation-oriented companies into penny stock territory.
Which beaten-down innovation stocks are worth checking out right now? Although these names are still exceedingly high-risk, I think aggressive investors may want to consider buying shares of Precigen (NASDAQ: PGEN) , Rigel Pharmaceuticals (NASDAQ: RIGL) , and 23andMe Holding Company (NASDAQ: ME) right now. Read on to find out why these three low-priced equities might be a tremendous wealth escalator for patient shareholders.
Image Source: Getty Images.
For further details see:
3 Penny Stocks That Could Make You Filthy Rich